Hiroaki Fujimori
- Oncology top 10%
- PARP inhibition in cancer therapy 10
- Cancer-related Molecular Pathways 4
- Hepatology top 10%
-
- DNA Repair Mechanisms 13
- Pluripotent Stem Cells Research 5
- Epigenetics and DNA Methylation 3
- Renal and related cancers 3
- RNA modifications and cancer 3
-
- Microtubule and mitosis dynamics 4
- Co-authors
- Mitsuko MasutaniHirobumi TeraokaTakahisa HiraiRyuichi OkayasuKenichi YoshiokaYujiro TanakaKenichi TeramotoKeiko Shimizu‐Saito
- Cited by
- OncologyHepatologyMolecular Biology
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Hiroaki Fujimori
25 papers receiving 610 citations
Peers
Comparison fields: 5 of 66
- Oncology 281
- Hepatology 65
- Molecular Biology 462
- Cancer Research 71
- Physiology 21
Countries citing papers authored by Hiroaki Fujimori
This map shows the geographic impact of Hiroaki Fujimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Fujimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Fujimori more than expected).
Fields of papers citing papers by Hiroaki Fujimori
This network shows the impact of papers produced by Hiroaki Fujimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Fujimori. The network helps show where Hiroaki Fujimori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroaki Fujimori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2019 | 15 | |
| 3 | 2018 | 17 | |
| 4 | 2016 | 8 | |
| 5 | 2016 | 41 | |
| 6 | 2015 | 19 | |
| 7 | 2015 | 11 | |
| 8 | 2015 | 35 | |
| 9 | 2013 | 25 | |
| 10 | 2013 | 43 | |
| 11 | 2013 | 13 | |
| 12 | 2013 | 23 | |
| 13 | 2013 | 3 | |
| 14 | 2012 | 59 | |
| 15 | 2012 | 29 | |
| 16 | 2011 | 33 | |
| 17 | 2010 | 67 | |
| 18 | 2008 | 13 | |
| 19 | 2005 | 21 | |
| 20 | 2004 | 88 |
About Hiroaki Fujimori
Hiroaki Fujimori is a scholar working on Oncology, Molecular Biology and Cell Biology, having authored 25 papers that have together received 619 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (13 papers), PARP inhibition in cancer therapy (10 papers), Pluripotent Stem Cells Research (5 papers), Microtubule and mitosis dynamics (4 papers), Cancer-related Molecular Pathways (4 papers), Epigenetics and DNA Methylation (3 papers), Renal and related cancers (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (281 citations), Hepatology (65 citations) and Molecular Biology (462 citations). Hiroaki Fujimori has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Mitsuko Masutani, Hirobumi Teraoka, Takahisa Hirai, Ryuichi Okayasu, Kenichi Yoshioka, Yujiro Tanaka, Kenichi Teramoto, Keiko Shimizu‐Saito, Kinji Asahina and Hidenori Shirai. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.